Home/Filings/4/0001415889-24-019904
4//SEC Filing

DOBMEIER ERIC 4

Accession 0001415889-24-019904

CIK 0001817713other

Filed

Jul 21, 8:00 PM ET

Accepted

Jul 22, 8:04 PM ET

Size

11.5 KB

Accession

0001415889-24-019904

Insider Transaction Report

Form 4
Period: 2024-07-19
Transactions
  • Award

    Common Stock

    2024-07-19+5,0005,000 total
  • Award

    Stock Option (Right to Buy)

    2024-07-19+8,3508,350 total
    Exercise: $44.68Exp: 2034-07-18Common Stock (8,350 underlying)
  • Award

    Common Stock

    2024-07-19+2,5007,500 total
  • Award

    Stock Option (Right to Buy)

    2024-07-19+16,70016,700 total
    Exercise: $44.68Exp: 2034-07-18Common Stock (16,700 underlying)
Footnotes (4)
  • [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in thirty-six equal monthly installments over a three year period, subject to the Reporting Person's continuous service on each such date.
  • [F2]Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date.
  • [F3]The shares subject to the option will vest in thirty-six equal monthly installments over three years, subject to the Reporting Person's continuous service on each such date.
  • [F4]The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date.

Issuer

Janux Therapeutics, Inc.

CIK 0001817713

Entity typeother

Related Parties

1
  • filerCIK 0001202785

Filing Metadata

Form type
4
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 8:04 PM ET
Size
11.5 KB